In the tumor parenchyma and stroma, no significant differences in the CD4 immunoreactions were observed between patients with tumor diameters ≤5 cm and patients with tumor diameters >5 cm (both P>0.05; Tables I and II). The gene discussed is CD4; the disease is neoplasm.